Sg3 Management, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.87 - $11.11 $154,575 - $249,975	-22,500 Closed	0 $0
Q4 2021 Feb 15, 2022	BUY	$7.7 - $37.13 $127,050 - $612,645	16,500 Added 275.0%	22,500 $220,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $158,760 - $222,900	6,000 New	6,000 $204,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $441,854 - $647,325	-13,500 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $545,265 - $765,855	13,500 New	13,500 $605,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.